Daniel A. Peisert
2018 - DepoMed
In 2018, Daniel A. Peisert earned a total compensation of $955.4K as Senior Vice President and Chief Financial Officer at DepoMed.
Compensation breakdown
| Non-Equity Incentive Plan | $114,722 |
|---|---|
| Salary | $319,167 |
| Stock Awards | $498,246 |
| Other | $23,263 |
| Total | $955,398 |
Peisert received $498.2K in stock awards, accounting for 52% of the total pay in 2018.
Peisert also received $114.7K in non-equity incentive plan, $319.2K in salary and $23.3K in other compensation.
Rankings
In 2018, Daniel A. Peisert's compensation ranked 9,415th out of 14,244 executives tracked by ExecPay. In other words, Peisert earned more than 33.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,415 out of 14,244 | 34th |
Division Manufacturing | 3,773 out of 5,759 | 35th |
Major group Chemicals And Allied Products | 1,421 out of 2,122 | 33rd |
Industry group Drugs | 1,196 out of 1,811 | 34th |
Industry Pharmaceutical Preparations | 924 out of 1,385 | 33rd |
Source: SEC filing on April 8, 2019.
Peisert's colleagues
We found six more compensation records of executives who worked with Daniel A. Peisert at DepoMed in 2018.
2018
Arthur Higgins
DepoMed
Chief Executive Officer
2018
Stanley Bukofzer
DepoMed
Senior Vice President and Chief Scientific and Technical Officer
2018
Phillip Donenberg
DepoMed
Chief Financial Officer
2018
August Moretti
DepoMed
Chief Financial Officer
2018
Matthew Gosling
DepoMed
General Counsel
2018
Santosh Vetticaden
DepoMed
Chief Medical Officer
News
Assertio Holdings CEO Arthur Higgins' 2020 pay falls 48% to $2.5M
April 12, 2021
Egalet CEO Arthur Higgins' 2019 pay rises 2% to $4.9M
April 20, 2020
DepoMed CEO Arthur Higgins' 2019 pay rises 2% to $4.9M
April 20, 2020
Egalet CEO Arthur Higgins' 2018 pay stays at $4.8M
November 6, 2019
DepoMed CEO Arthur Higgins' 2018 pay stays at $4.8M
April 8, 2019